Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Health insurance premiums rose nearly 3x the rate of worker earnings over the past 25 years - 2Bayer reports positive results for blood thinner after 2023 setback
- 3Watch Rocket Lab launch Japanese technology-demonstrating satellite to orbit tonight
- 4Scientists are getting our robotic explorers ready to help send humans to Mars
- 5Instructions to Explore the Universe of Vehicle Leases
- Activist vessel collides with krill trawler in Antarctic confrontation
- 7 Fast Approaches to Let loose Space on Your Telephone in a flash
- Kremlin: Russian troops conquer Pokrovsk after year of intense combat
- Here's what the Artemis 2 astronauts will be doing on each day of NASA's historic moon mission
- Europe’s Airlines Run Low on Fuel
- Three killed as unfinished building collapses on church service in Ghana
- New York to require social media platforms to display mental health warnings
- Witness the elegance of the cosmic butterfly in a remarkable telescope photo
- Israel and Iran continue tit-for-tat attacks
